Histogenics Corp and Ocugen Inc to Discuss the Merger Agreement Transcript
Adam, you may begin.
Good morning everyone. In connection with the proposed merger transaction described during this call, Histogenics Corporation and Ocugen intend to file relevant materials with the Securities and Exchange Commission or the SEC, including a registration statement on Form S-4 that will contain a perspective, a proxy statement and an information statement.
Investors and security holders of Histogenics and Ocugen are urged to read these materials when they become available, because they will contain important information about Histogenics, Ocugen and the merger.
The proxy statement, perspectives information statement and other relevant materials, when they become available and any other documents filed by Histogenics with the SEC may be obtained free of charge at the SEC website at SEC.gov.
In addition, investors and security holders may obtain free copies of the document filed with the SEC by Histogenics by directing a written request to Histogenics Corporation, care of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
